Annual report [Section 13 and 15(d), not S-K Item 405]

Income Taxes (Tables)

v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Components of Company's Profit (Loss) Before Income Taxes and Tax Provisions

The components of the Company’s profit (loss) before income taxes are as follows:

 

 

Year Ended

 

 

 

December 31,

 

(in thousands)

 

2024

 

 

2023

 

Profit (loss) before income taxes:

 

 

 

 

Domestic

 

 

(81,310

)

 

 

(75,028

)

Foreign

 

 

(5,499

)

 

 

(29,125

)

Total

 

$

(86,809

)

 

$

(104,153

)

 

 

The components of the income tax expense (benefit) are as follows:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2024

 

 

2023

 

Current Provision

 

 

 

 

 

 

Federal

 

$

 

 

$

 

State

 

 

 

 

 

 

Foreign

 

38

 

 

 

83

 

Total current expense (benefit)

 

$

38

 

 

 

83

 

Deferred Provision

 

 

 

 

 

 

Federal

 

 

 

 

 

 

State

 

 

 

 

 

 

Foreign

 

 

(1,281

)

 

 

(669

)

Total deferred expense (benefit)

 

 

(1,281

)

 

 

(669

)

Total income tax expense (benefit)

 

$

(1,243

)

 

$

(586

)

Schedule of Overall Effective Income Tax Rate

The overall effective tax rate differs from the statutory US federal tax rate as follows:

 

 

 

Year Ended December 31,

 

 

 

% of Pretax Profit (Loss)

 

 

 

2024

 

 

2023

 

Statutory US federal tax rate

 

 

21.00

%

 

 

21.00

%

State income taxes, net of federal benefit

 

 

1.71

 

 

 

4.04

 

Stock-based compensation

 

 

(2.38

)

 

 

(2.19

)

Nondeductible expenses

 

 

(0.13

)

 

 

(0.15

)

Goodwill impairment

 

 

 

 

 

(6.06

)

Fair market value change in warrants and earn out liabilities

 

 

(0.84

)

 

 

 

Transaction costs

 

 

(1.20

)

 

 

 

Officer's compensation

 

 

(0.19

)

 

 

(0.13

)

Research and development credits

 

 

(2.87

)

 

 

2.56

 

Valuation allowance

 

 

(13.61

)

 

 

(18.11

)

Change in statutory tax rate

 

 

(0.05

)

 

 

(0.04

)

Other

 

 

 

 

 

(0.36

)

Effective tax rate

 

 

1.44

%

 

 

0.56

%

 

Schedule of Components of the Company's Net Deferred Tax Assets

Significant components of the Company’s net deferred tax assets are as follows:

 

 

 

December 31,

 

(in thousands)

 

2024

 

 

2023

 

Deferred tax assets

 

 

 

 

 

 

Lease liability

 

$

7,938

 

 

$

10,493

 

Capitalized research and development costs

 

 

11,719

 

 

 

14,596

 

Stock compensation

 

 

1,931

 

 

 

2,175

 

Reserves

 

 

1,106

 

 

 

689

 

Deferred revenue

 

 

667

 

 

 

1,298

 

Accrued expenses

 

 

672

 

 

 

564

 

Inventory reserves

 

 

637

 

 

 

670

 

Long term settlement payable

 

 

1,304

 

 

 

 

Net operating losses

 

 

62,760

 

 

 

42,646

 

Research and development credits

 

 

12,684

 

 

 

15,465

 

Other credits

 

 

459

 

 

 

407

 

Gross deferred tax assets

 

$

101,877

 

 

$

89,003

 

Less: Valuation allowance

 

 

(90,594

)

 

 

(78,576

)

Deferred tax liabilities

 

 

 

 

 

 

Right-of-use assets

 

 

(7,432

)

 

 

(8,966

)

Deferred expenses

 

 

(132

)

 

 

(125

)

Acquired intangible assets

 

 

(2,814

)

 

 

(3,218

)

Other assets - license

 

 

(1,315

)

 

 

 

Depreciation

 

 

(25

)

 

 

(203

)

Loss on sale of assets

 

 

(345

)

 

 

(20

)

Net deferred tax assets

 

$

(780

)

 

$

(2,105

)

Schedule of Deferred Income Tax Asset Valuation Allowance

The following table presents the changes in the balance of the Company’s deferred income tax asset valuation allowance:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2024

 

 

2023

 

Balance at beginning of year

 

$

78,576

 

 

$

59,514

 

Additions charged to expense

 

 

12,018

 

 

 

19,062

 

Balance at end of year

 

$

90,594

 

 

$

78,576